Please use this identifier to cite or link to this item:
|Title:||Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.|
|Citation:||Vedantham V, Kim R. Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice. Indian Journal of Ophthalmology. 2006 Jun; 54(2): 133-7|
|Abstract:||Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard treatment of macular edema, is associated with significant complications and an improvement in visual acuity is unsatisfactory. Intravitreal injection of corticosteroids (especially triamcinolone acetonide) is an emerging treatment modality in the management of diabetic macular edema. This article presents an overview of the principles, technique and complications associated with this procedure.|
|Appears in Collections:||Indian Journal of Ophthalmology|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.